ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,886,000 | -93.3% | 59,931 | -94.1% | 0.02% | -94.0% |
| Q1 2020 | $42,988,000 | -0.1% | 1,017,487 | +1.2% | 0.27% | +29.0% |
| Q4 2019 | $43,011,000 | +18.2% | 1,005,406 | -0.5% | 0.21% | +10.1% |
| Q3 2019 | $36,373,000 | +36.1% | 1,010,663 | +1.1% | 0.19% | +37.2% |
| Q2 2019 | $26,733,000 | -14.2% | 1,000,118 | +2.1% | 0.14% | -35.1% |
| Q3 2016 | $31,151,000 | +0.5% | 979,303 | +2.5% | 0.21% | -1.9% |
| Q2 2016 | $31,000,000 | +7.5% | 955,027 | -7.4% | 0.22% | +7.5% |
| Q1 2016 | $28,837,000 | +22.3% | 1,031,373 | +55.9% | 0.20% | +26.6% |
| Q4 2015 | $23,583,000 | -42.1% | 661,516 | -46.3% | 0.16% | +13.7% |
| Q3 2015 | $40,764,000 | – | 1,232,708 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |